Nutra Pharma CorpOver The Counter Market:NPHC
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Mar 22, 2024
Press Release: Nutra Pharma Corp. Reaches Settlement with SEC, from 5:44PM ET on Friday Mar 22, 2024 by Dow Jones
5:44PM ET on Friday Mar 22, 2024 by Dow JonesNutra Pharma Corp. Reaches Settlement with SEC, from 4:39PM ET on Friday Mar 22, 2024 by Dow Jones
4:39PM ET on Friday Mar 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nutra Pharma Corp | 759.7K | 0.2x | --- |
Endonovo Therapeutics Inc | 902.1K | 0.0x | --- |
Health Advance Inc | 725.2K | 0.0x | --- |
Regenicin Inc | 767.4K | -0.8x | --- |
Bellerophon Therapeutics Inc | 698.5K | -0.1x | --- |
Capstone Holding Corp | 819.6K | -0.8x | --- |
Company Information
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, is an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain and inflammation in horses. Its Luxury Feet is an over-the-counter pain reliever designed specifically to treat foot pain and inflammation, especially for women who wear high heels and stilettos. The Company also manufactures Cell Defender, ZMUNITY, and Avini Plus Energy, among others.
Contact Information
- Headquarters
- 1537 NW 65th AvenuePLANTATION, FL, United States 33313
- Phone
- 954-509-0911
- Fax
- 877-895-5647
Executives
- Chairman of the Board, Chief Executive Officer, Chief Financial Officer
- Michael Flax
- Chief Scientific Officer
- Dale Vanderputten
- Director
- Stewart Lonky
- Director
- Garry Pottruck
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $759.7K |
|---|---|
Revenue (TTM) | $247.8K |
Shares Outstanding | 7.6B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.11 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 0.2x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 0.1x |
Operating Margin | -592.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
